PROYECTOS EUROPEOS
Proyecto DIRNANO DIRNANO
Directing the immune response through designed nanomaterials
date_range
Duración del 01 de octubre de 2020 al 30 de septiembre de 2024
(48 meses)
euro
259.904,00 EUR
De ámbito Europeo.
Investigadores/as
Francisco
Corzana López
Responsable
Publicaciones relacionadas con el proyecto (6)
Mostrar por tipología2023
-
Methyl-to-Ethyl Replacement Makes the Difference: Structure-Guided Design of a New Cancer Vaccine Based on a Tn An-gen Surrogate
VI RSEQ Chemical Biology Group Meeting - ChemBio VI
-
Structure-guided design of unnatural Mucin-1 biomimetics for the development of cancer therapeutic nano-vaccines and diagnostic assays
4th Regular Meeting of the DIRNANO consortium
-
Impact of structure-guided cancer nano-vaccine candidates and their respective nanoformulations in preclinical cancer models
3rd Regular Meeting of the DIRNANO consortium
-
Impact of structure-guided cancer nano-vaccine candidates and their respective nanoformulations in preclinical cancer models & biosensor development
5th Regular Meeting of the DIRNANO consortium
2022
-
Directing the immune response through designed nanomaterial. Winter School Presentation
Winter School of the DIRNANO consortium
-
Directing the immune response through designed nanomaterials. Progress Report
1st Regular Meeting of the DIRNANO consortium
Datos de investigación relacionados
- POSTER Impact of structure-guided cancer nano-vaccine candidates and their respective nanoformulations in preclinical cancer models & biosensor development
- POSTER Structure-guided design of unnatural Mucin-1 biomimetics for the development of cancer therapeutic nano-vaccines and diagnostic assays
- POSTER Impact of structure-guided cancer nano-vaccine candidates and their respective nanoformulations in preclinical cancer models
- POSTER Methyl-to-Ethyl Replacement Makes the Difference: Structure-Guided Design of a New Cancer Vaccine Based on a Tn An-gen Surrogate
- PRESENTATION 2nd Regular Meeting of the DIRNANO consortium; ESR14